Anaplastic lymphoma kinase rearrangement-associated renal cell carcinoma: Rare subset case report

Hamad S AlAkrash1, Hisham M Ghabbani1, Faisal A AlSaleh2

  • 1Urology Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Urology Case Reports
|August 6, 2024
PubMed

Insights

Anaplastic lymphoma kinase rearrangement-associated renal cell carcinoma (ALK-RCC) is a rare kidney cancer. ALK inhibitors show promise as a targeted therapy for this unique subtype.

Area of Science:

  • Oncology
  • Genetics
  • Pathology

Background:

  • Anaplastic lymphoma kinase rearrangement-associated renal cell carcinoma (ALK-RCC) is a rare kidney cancer subtype.
  • Its rarity presents challenges in management and treatment.
  • Genetic rearrangements involving the ALK gene define this specific cancer.